↓ Skip to main content

Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer

Overview of attention for article published in Breast Cancer Research, March 2013
Altmetric Badge

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
63 Mendeley
Title
Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer
Published in
Breast Cancer Research, March 2013
DOI 10.1186/bcr3395
Pubmed ID
Authors

Areti Strati, Sabine Kasimir-Bauer, Athina Markou, Cleo Parisi, Evi S Lianidou

Abstract

INTRODUCTION: Comparison studies between different analytical methodologies for circulating tumor cells (CTC) detection and molecular characterization are urgently needed, since standardization of assays is essential before their use in clinical practice. METHODS: We compared three different CTC molecular assays. To avoid discrepancies due to pre-analytical errors we used the same cDNAs throughout our study. CTC were isolated using anti-EpCAM and anti-MUC1 coated magnetic beads from 2 × 5 ml of peripheral blood of 254 early and 51 metastatic breast cancer patients and 30 healthy individuals. The same cDNAs were analyzed by: a) singleplex RT-qPCR assay for CK-19; b) multiplex RT-qPCR for CK-19, HER-2, MAGE- A3, and PBGD; and c) a commercially available molecular assay (AdnaTest BreastCancer) for GA733-2, MUC-1, HER-2 and beta-actin. RESULTS: In early breast cancer, CK-19 RT-qPCR, multiplex RT-qPCR and the AdnaTest, were positive for the presence of CTC in 14.2%, 22.8% and 16.5% subjects, respectively. The concordance between the AdnaTest and CK-19 RT-qPCR was 72.4% while between the AdnaTest and multiplex RT-qPCR was 64.6%. In patients with overt metastasis, CK-19 RT-qPCR, multiplex RT-qPCR and the AdnaTest were positive in 41.2%, 39.2% and 54.9% patients, respectively. The concordance between the AdnaTest and CK-19 RT-qPCR was 70.6% while between the AdnaTest and multiplex RT-qPCR was 68.6%. CONCLUSIONS: All CTC assays gave similar results in about 70% of cases. Better agreement was found in the metastatic setting, possibly explained by the higher tumor load in this group. Discordances could be attributed to the different gene transcripts used to evaluate CTC positivity. Our results indicate the importance of CTC heterogeneity for their detection by different analytical methodologies.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Egypt 1 2%
Unknown 62 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 21%
Student > Master 8 13%
Other 6 10%
Student > Bachelor 6 10%
Professor > Associate Professor 6 10%
Other 14 22%
Unknown 10 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 15 24%
Medicine and Dentistry 13 21%
Biochemistry, Genetics and Molecular Biology 10 16%
Chemistry 7 11%
Nursing and Health Professions 1 2%
Other 5 8%
Unknown 12 19%